Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
May 4 07:22
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Dec 5, 2023 08:40
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 9, 2023 03:11
Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144
Aug 11, 2023 03:18
Amgen | 424B2: Prospectus
Feb 17, 2023 08:41
Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 16, 2023 08:04
Amgen | 424B3: Prospectus
Feb 14, 2023 22:20
Amgen | 424B2: Prospectus
Aug 17, 2022 05:20
Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 16, 2022 06:06
Amgen | 424B3: Prospectus
Aug 15, 2022 20:48
Amgen | 424B2: Prospectus
Feb 19, 2022 05:09
Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 18, 2022 06:23
Amgen | 424B3: Prospectus
Feb 17, 2022 21:53
Amgen | 424B2: Prospectus
Aug 7, 2021 05:03
Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 6, 2021 07:28
Amgen | 424B3: Prospectus
Aug 5, 2021 20:31
Amgen | EFFECT: Others
Apr 16, 2021 12:15
Amgen | 424B3: Prospectus
Apr 16, 2021 04:13
Amgen | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Apr 7, 2021 04:02
Amgen | S-4: Registration of securities issued in business combination transactions
Feb 10, 2021 05:45
No Data
No Data